Industry News

Kester Capital exits Frontier Medical Group

June 3rd, 2021

Kester Capital exits Frontier Medical Group

Kester Capital exits Frontier Medical Group, a specialist medical device business. 

Kester Capital acquired Frontier Medical in 2013, and helped it to grow from a UK focused family-owned business into a manufacturer and supplier of Pressure Ulcer Prevention and Infection Prevention products to healthcare providers globally. During Kester Capital’s investment period, the Wales-headquartered business experienced significant international expansion and new product development, resulting in an increase of export revenues by 160% and total revenues by over 60%.

Having facilitated the succession of the founder through the recruitment of a new senior leadership team led by Simon Jackson, Frontier Medical grew through international expansion as well as through strategic acquisition to cement its leading position in the skin and wound care market.

Cameron Crockett, Managing Partner of Kester Capital, said: “We would like to thank the Frontier team, led by Simon Jackson, Matthew Bambery and Frank Collins, for their exceptional work over the last seven years. It has been a pleasure to partner with such an outstanding team and we wish them, the wider team and the business every success for the future.”

Simon Jackson, CEO at Frontier Medical, added: “Kester Capital has been a great long-term partner and strong supporter of our ambitious plans. Together we have been able to achieve a great result for shareholders and most importantly a very favourable outlook for our business.”

Share this article
© Copyright 2024